Actelion Denied Judgment In Tracleer Antitrust Suit

Law360, Chicago (October 21, 2013, 8:00 PM EDT) -- A New Jersey federal judge on Monday rejected Actelion Pharmaceuticals Ltd.’s bid for a quick end to its lawsuit claiming antitrust laws don’t require it to supply its Tracleer blood pressure medicine to aid in developing generics, ruling in favor of several generic-drug makers and ordering the case to proceed to discovery.

In a brief order, U.S. District Judge Noel L. Hillman denied Actelion’s motion for judgment on the pleadings and to dismiss counterclaims filed by the defendants, which include Apotex Inc., Roxane Laboratories and Actavis...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.